Hamburg-based Evotec AG is a drug design company that uses research alliances and development partnerships with other pharmaceutical companies and biotech firms to create approaches for developing new pharmaceutical products. CEO Werner Lanthaler is a ray of light when it comes to creative briefs.
The language of biotech is hard for shareholders to get their heads round. Which is why we made sure that the 2011 annual report presented all the facts, figures, projects and the pipeline as clearly as possible. The publication was all about using plain language. When it came to visual inspiration we needed look no further than an eye test – a byword for clarity.